INTRODUCTION {#SEC1}
============

Cell fate decisions are regulated at both transcriptional and post-transcriptional levels, through complex gene circuits that often display feedforward and feedback regulatory loops involving transcription factors and other factors, in particular microRNAs (miRNAs) ([@B1]). Neuronal differentiation is a paradigm for biological processes that are finely controlled through multiple loops of regulation ([@B2],[@B3]). A central factor in this process is the Repressor Element 1-silencing transcription factor (REST), which represses a large number of neuron-specific genes in non-neuronal cells or in undifferentiated neural progenitors ([@B4]). REST binds to a conserved 21--23 bp sequence and often recruits a repressive complex containing the REST corepressor 1 (RCOR1, also known as CoREST) and several chromatin modifying factors ([@B7]). Some of the genes targeted by the REST complex encode miRNAs that have critical functions for neural development ([@B12],[@B13]). These miRNAs, like miR-9/9\* and miR-124, have multiple targets during neurogenesis, in particular REST itself as well as REST cofactors ([@B14]). The decreased expression of REST, which relieves the repression of neuronal genes, coincides with the exit from cell cycle to license progenitors for their terminal neuronal differentiation process ([@B10],[@B17],[@B19]).

Another regulatory loop during neurogenesis involves the family of RNA polymerase II carboxyl-terminal domain (CTD) small phosphatase (CTDSP) proteins (also known as small CTD phosphatase or SCP1 to 3). It has been shown that CTDSP1 interacts with the REST complex and contributes to the transcriptional silencing of neuronal genes ([@B20]). Each of the three paralog genes *CTDSP1, CTDSP2* and *CTDSPL* encodes an intronic miRNA precursor of the miR-26a/b family, respectively pri-mir-26b, 26a2 and 26a1. These miRNAs can target their host transcripts in a negative feedback loop of regulation ([@B21]). This feedback control is essential for neurogenesis in zebrafish, but it cannot take place in undifferentiated neural stem cells due to the incomplete maturation of the miR-26b precursor, the ortholog of mammalian miR-26a2 ([@B21]). The mechanism that blocked the processing of zebrafish miR-26b precursor remained uncharacterized.

Because of their multiple molecular activities, RNA helicases regulate virtually all gene expression steps ([@B22]). In particular, the highly related ATP-dependent DEAD box helicases 5 (DDX5, also known as p68) and DDX17 (p72) have multiple and partially redundant functions in the regulation of gene expression ([@B25]), and they emerge as key factors to regulate cell fate switches and biological transitions ([@B26]). One of their functions is to coregulate the activity of various transcription factors, including the Estrogen Receptor alpha, MyoD or RORγt ([@B29],[@B30]). The interaction of DDX5 and DDX17 with MyoD is central during skeletal myoblast differentiation since it regulates the expression of master myogenic transcription factors and miRNAs ([@B26],[@B31]). Other functions of DDX5 and DDX17 include the regulation of the nuclear maturation of some miRNA precursors through their interaction with the Microprocessor components Drosha and DGCR8 ([@B32]), and the regulation of pre-mRNA alternative splicing ([@B26],[@B37]).

Here, we report a new function of DDX17 as a major regulator of the REST complex. DDX17 controls the binding of REST to its target promoters and corepresses neuronal gene expression. Moreover, DDX17 regulates the expression of miRNAs that are required for the coordinated loss of the REST complex during the early phases of neurogenesis. Our work also uncovers an intronic regulatory region that negatively impacts on both miR-26a2 processing and splicing of its host intron in absence of DDX5 and DDX17.

MATERIALS AND METHODS {#SEC2}
=====================

Cell culture, differentiation and transfections {#SEC2-1}
-----------------------------------------------

The human SH-SY5Y neuroblastoma cell line (ECACC) was cultured in DMEM/F12 medium complemented with 10% FBS, 1% glutamine and 1% penicilline/streptomycine. The CLBMA2 cell line ([@B44]) (see also [Supplementary Materials and Methods](#sup1){ref-type="supplementary-material"} for details) was cultured in RPMI medium complemented with 10% FBS, 1% glutamine and 1% penicilline/streptomycine. Cells were differentiated using 10 μM all-*trans* retinoic acid (ATRA, Sigma) for up to 2 weeks, as indicated in the figures. In standard transfections experiments on SH-SY5Y cells, 20 nM of siRNA were mixed with Lipofectamine RNAiMax (Thermo Fisher Scientific) following the manufacturer\'s instructions and cells were harvested 48 h after transfection, unless indicated. For double siRNA treatments, we used a total of 40 nM siRNA (20 nM si*DDX5/DDX17* + 20 nM si*REST*). In this case the single depletion were also carried out with a total of 40 nM siRNA: 20 nM si*DDX5/DDX17* or 20 nM si*REST* complemented with 20 nM of control siRNA. For experiments using 2′-*O*-methylated antisense RNA oligonucleotides (AON), 10 nM of siRNA were mixed with 100 nM of AONs. Finally, for overexpression of miRNAs, 10 nM of pre-miR miRNA precursors (\#AM17100, Thermo Fisher Scientific) were transfected with Lipofectamine RNAiMax as for siRNAs.

Stable inducible MCF7 lines expressing DDX5 and DDX17 were cultured as previously described ([@B26],[@B43]).

Luciferase assays {#SEC2-2}
-----------------

The 3′ half of the *DDX17* 3′ UTR, containing predicted binding sites for miR-26a/b and miR-9 (according to TargetScanHuman v6.2), was cloned in the psiCHEK-2 plasmid (Promega) downstream of the Renilla luciferase gene. This plasmids also contain the Firefly luciferase gene used for internal normalization of the data. A mutant derivative construct (made by Eurofins Genomics) was obtained by directed mutagenesis of the wild-type psiCHEK-DDX17 plasmid to delete four nucleotides within the predicted miR-26a/b binding site. Similarly, we cloned in the psiCHEK-2 plasmid the first 1000 bp of the *REST* 3′UTR, which contains the most conserved of the predicted binding sites for miR-26a/b, and we engineered a 4-bp deletion mutant from this wild-type construct.

SH-SY5Y cells were seeded (22 500 cells per well) in 96-well plates and transfected the day after with 7.5 ng of luciferase reporter along with 10 nM pre-miR precursor (control or pre-miR-26a or pre-miR-26b, ThermoFisher/Life Technologies), using JetPrime^®^ (Polyplus transfection). Luciferase expression was measured 24 h after transfection directly in the plates using the Dual-Glo^®^ Luciferase Assay System (Promega), as recommended by the manufacturer. Data were expressed as the ratio of Renilla (test) to Firefly (internal control) luminescence, and normalized to the ratio obtained with the control pre-miR.

Proximity ligation assay {#SEC2-3}
------------------------

*In situ* proximity ligation assay (PLA) were performed on SH-SY5Y cells using the Duolink in Situ Kit (Sigma-Aldrich), as recommended by the manufacturer. The following antibodies were used: DDX17 proteins (ab71958, Abcam), DDX5 (Pab204, Millipore) and REST (07-579, Millipore). Quantification of the PLA foci was based on a previously described macro ([@B45]) that was optimized to detect foci within nuclei of human cells. The macro was designed to automatically detect and process batches of microscope-coupled acquisitions, as detailed in [Supplementary Materials and Methods](#sup1){ref-type="supplementary-material"}.

Co-immunoprecipitation and western blotting {#SEC2-4}
-------------------------------------------

Total protein extraction was carried out as previously described ([@B26]). Primary antibodies used for Western-blotting: DDX5 (ab10261, Abcam), DDX17 (ab24601, Abcam), MYCN (sc-56729, SantaCruz), NCAM1 (ab18277, Abcam), REST (07-579 Millipore), CoREST (07-455 Millipore), Synapsin-1 (D12G5, Ozyme), Actin (sc-1616, SantaCruz) and GAPDH (sc-32233, SantaCruz).

For co-immunoprecipitation, SH-SY5Y cells (7 × 10^6^ to 8 × 10^6^ per assay) were harvested and lysed in a lysis buffer containing 20 mM Tris--HCl pH 7.5, 150 mM NaCl, 2 mM EDTA, 1% NP40, 10% glycerol, cOmplete protease inhibitor cocktail (Roche) (1 ml of lysis buffer was used for each 10 cm Petri dish). Lysis was carried out at 4°C for 30 min under rotation. The lysate was centrifuged for 15 min at 13 000 rpm to remove cell debris and then split in equal amounts for each assay. Each fraction received 5 μg of antibody and the incubation was left overnight at 4°C under rotation. The following antibodies were used for IP: rabbit anti-DDX17 (ProteinTech 19910-1-AP) or a control rabbit antibody (anti-SSU72, Cell Signalling D3I2D), and goat anti-DDX5 (Abcam ab10261) or control Rabbit IgG (Santa Cruz). The next day, the different lysate/antibody mixtures were incubated with 50 μl Dynabeads^®^ Protein G (Thermo Fisher) blocked with salmon sperm DNA and bovine serum albumine, for 5 h at 4°C under rotation. Bead were then washed three times with lysis buffer. Elution was performed by boiling for 5 min in SDS-PAGE loading buffer prior to analysis by western-blotting.

Chromatin immunoprecipitation {#SEC2-5}
-----------------------------

The composition of all buffers is given in [Supplementary Materials and Methods](#sup1){ref-type="supplementary-material"}. SH-SY5Y cells were cross-linked with 1% formaldhehyde for 10 min. Cross-linking was stopped by addition of 0.125 M glycin and cells were harvested and centrifuged. Nuclei were isolated by sonication using a Covaris S220 (2′ peak power: 75; duty factor: 2; cycles/burst: 200), pelleted by centrifugation at 3000 rpm for 5 min at 4°C, washed once with FL buffer and resuspended in 1 ml Shearing buffer. Chromatin was sheared to fragments of about 200 bp using a Covaris S220 (20′ peak power: 140; duty factor: 5; cycles/burst: 200), and debris were eliminated by 10 minutes centrifugation at 13 200 rpm at 4°C. 30 μg of chromatin were diluted 10 times in Buffer D and pre-cleared for 30 min at 4°C on a rotating wheel with 30 μl Dynabeads^®^ Protein A (Thermo Fisher) blocked for 1 h with 20 μg salmon sperm DNA. Beads were removed, 1% was collected as input fraction and the rest of the chromatin was immunoprecipitated overnight at 4°C with 5 μg of the following antibodies: rabbit anti-DDX17 (ProteinTech 19910-1-AP), rabbit anti REST (Millipore, 07-579), rabbit anti-EHMT2 (Cell Signaling Technologies, 3306S) or control rabbit IgG (Cell Signaling Technologies). Immunoprecipitates were bound to 30 μl Dynabeads^®^ Protein A (Thermo Fisher) blocked as above, for 1.5 h at 4°C under rotation. Beads were washed under increasing stringency (see table below) and reverse cross-link was carried out by incubation in Elution buffer for 4 h at 65°C with 40 μg Proteinase K in a Thermomixer. DNA was purified by phenol--chloroform extraction and ethanol precipitation and resuspended in ultra-pure water for qPCR analysis.

RNA extraction and PCR analyses {#SEC2-6}
-------------------------------

Total RNA were isolated using TriPure Isolation Reagent (Roche). For reverse transcription, 1--2 μg of purifed RNAs were treated with Dnase I (ThermoFisher) and retrotranscribed using Maxima reverse transcriptase (ThermoFisher), as recommended by the supplier. Potential genomic DNA contamination was verified by performing negative RT controls in absence of enzyme, and by including controls with water instead of cDNA in PCR and qPCR assays. See also the [Supplementary Materials and Methods](#sup1){ref-type="supplementary-material"} for more details.

All PCR analyses were performed on 0.5 ng cDNA using 0.5 U GoTaq^®^ DNA polymerase (Promega), as detailed (including primers sequences) in [Supplementary Materials and Methods](#sup1){ref-type="supplementary-material"}.

Quantitative PCR analyses {#SEC2-7}
-------------------------

For quantitative analyses of global steady-state gene expression, primers were designed in regions of the transcript that are present in all mRNA isoforms and not submitted to alternative splicing changes, to be sure to quantify the overall expression of the gene. All primer sequences can be found in [Supplementary Materials and Methods](#sup1){ref-type="supplementary-material"}. The specificity and linear efficiency of all qPCR primers was first verified by establishing a standard expression curve with various amounts of human genomic DNA or cDNA. qPCR reactions were carried out on 0.625 ng cDNA using a LightCycler 480 System (Roche), with either the SYBR^®^ Green I Master Mix (Roche) or the SYBR^®^ Premix Ex Taq (Tli RNaseH Plus) (Takara), under thermocycling conditions that were recommenced by both manufacturers for this apparatus. Melting curves were systematically controlled to rule out the existence of non-specific products. Relative DNA levels were calculated using the ΔΔCt method (using the average Ct obtained from technical duplicates or triplicates) and were normalized to the expression of *18S* RNA.

Quantification of mature miRNAs was carried out using the miRCURY LNA Universal cDNA synthesis and SYBR Green PCR kit (Exiqon), with specific LNA primer sets, in full compliance with the manufacturer\'s instructions. qRT-PCR values were normalized relative to U6 snRNA level.

RNA-Seq and bioinformatics {#SEC2-8}
--------------------------

Stranded paired-end sequencing of total poly-A transcripts was performed on an Illumina HiSeq 2500 platform (Aros Applied Biotechnology, Aarhus, Denmark). Reads were mapped and analysed as detailed in [Supplementary Materials and Methods](#sup1){ref-type="supplementary-material"}. The differential gene analysis was carried out with DESeq2 package ([@B46]). Parameters for differential expression: adjusted *P*-value \< 0.05 and \[log~2~(FC)\] ≥ 0.35. All enrichment analyses for biological functions and transcription factor binding sites were carried out using the Enrichr analysis tool ([@B47]).

Prediction of RNA secondary structures with Mfold {#SEC2-9}
-------------------------------------------------

As the Mfold program ([@B48]) does not allow to predict the folding of long RNA sequences (maximum 800 bases), we used chimeric sequences of variable length that included the two regions regulated by DDX5 and DDX17, i.e. the exon 6 and the pri-mir-26a2. The default Mfold parameters were used. The picture presented in Figure [2](#F2){ref-type="fig"} shows a part of a typical structure predicted from a 500 nt-long sequence composed of: (i) a 200-nt fragment that includes full exon 6 and the beginning of intron 6; (ii) a 300-nt fragment centered on the miRNA hairpin. Note that a competing base-pairing between the proximal intronic sequence and the lower part of the pri-mir-26a2 hairpin was predicted whatever the length of the tested sequence (up to 800 nt).

RESULTS {#SEC3}
=======

DDX5 and DDX17 control the expression of specific miRNAs during neuronal differentiation {#SEC3-1}
----------------------------------------------------------------------------------------

Since DDX5 and DDX17 control the biogenesis of miRNAs during several differentiation processes ([@B26]), we asked whether those ubiquitously expressed proteins could play a similar role during neuronal differentiation. To this end, neuroblastoma SH-SY5Y cells were first treated for one day with a control siRNA or with an siRNA targeting both *DDX5* and *DDX17* genes (si*DDX5/DDX17*), and then with all-*trans* retinoic acid (ATRA) to induce their differentiation (Figure [1A](#F1){ref-type="fig"} and [B](#F1){ref-type="fig"}). We monitored by RT-qPCR the expression of several neuron-enriched miRNAs, which were selected on the basis of their function in neuronal cells and/or their induction by ATRA in neuroblastoma cells ([@B49],[@B50]). As expected, all tested miRNAs were induced by the ATRA treatment (Figure [1C](#F1){ref-type="fig"}, blue curves). However, in si*DDX5/DDX17*-treated cells the induction of eight out of the ten tested miRNAs was compromised (miR-26a/b, miR-9, miR-181a/b and miR-124) or strongly reduced (miR-212 and miR-132) after 3 days of ATRA treatment (Figure [1C](#F1){ref-type="fig"}, red curves). *DDX5* and *DDX17* silencing did not affect the expression of the other two miRNAs (miR-125b and miR-34a), denoting some selectivity (Figure [1C](#F1){ref-type="fig"}).

![DDX5 and DDX17 are required for the expression of specific miRNAs during neuronal differentiation. (**A**) Experimental outline. RNA analysis was carried out at day 0 (corresponding to undifferentiated SH-SY5Y cells pre-treated for 24 h with control siRNA or si*DDX5/DDX17*), and after 1, 2 and 3 days of ATRA treatment. Note that the combined silencing of *DDX5* and *DDX17* genes allows to study more easily the function of those proteins that have partially redundant functions and that cross-regulate each other ([@B26],[@B77]). (**B**) Western-blot analysis showing the depletion of DDX5 and DDX17 at day 0 of the time-course. \* non-specific band. (**C**) Quantitative RT-PCR (RT-qPCR) analysis showing the expression of mature miRNAs during time-course differentiation. Blue curves: Ctrl siRNA; red curves: si*DDX5/DDX17*. Data are represented as the mean values ± S.E.M. of independent experiments (*n* = 5) and normalized to the control sample (control siRNA, day 0), which was set to 1. \**P*-value \< 0.05; \*\**P*-value \< 0.01; ns: not significant (Student\'s *t*-test). (**D**) RT-qPCR analysis of the two miR-26a nuclear precursors (plain curves, black and dark blue respectively for pri-mir-26a1 and pri-mir-26a2) and their respective host genes (dashed curves, black and dark blue respectively for *CTDSPL* and *CTDSP2* mRNAs) during differentiation. Data for each curve are represented as the mean values ± S.E.M. of independent experiments (*n* = 5) normalized to the control sample (day 0), which was set to 1. (**E**) RT-qPCR analysis showing the effect of *DDX5/DDX17* silencing (red curves) on *CTDSP2* mRNA (dashed curves) and pri-mir-26a2 (plain curves) expression during time-course differentiation. Details are as in C.](gky545fig1){#F1}

Among the DDX5/DDX17-dependent neuronal miRNAs, we focused on miR-26a since the processing of its zebrafish ortholog is a crucial rate-limiting step during neurogenesis ([@B21]). Thus, we sought to determine whether DDX5 and DDX17 control transcriptionally or post-transcriptionally the expression of miR-26a in differentiating SH-SY5Y cells. In mammals, miR-26a is expressed from two different loci (*CTDSPL* and *CTDSP2*) that generate the primary precursors pri-mir-26a1 and pri-mir-26a2, respectively. Neither the *CTDSPL* mRNA nor the corresponding pri-mir-26a1 was induced upon ATRA treatment (Figure [1D](#F1){ref-type="fig"}, black curves). In contrast, expression of both the *CTDSP2* gene and the pri-mir-26a2 were steadily enhanced during differentiation, indicating that most of the induced miR-26a pool originates from the pri-mir-26a2 precursor in SH-SY5Y cells (Figure [1D](#F1){ref-type="fig"}, blue curves). We next analysed the ATRA-induced expression of *CTDSP2*/pri-mir-26a2 in absence of DDX5 and DDX17. Strikingly, we observed a strong accumulation of pri-mir-26a2 during differentiation upon *DDX5* and *DDX17* silencing (Figure [1E](#F1){ref-type="fig"}, compare red and blue plain curves), whereas *CTDSP2* mRNA level was not altered (Figure [1E](#F1){ref-type="fig"}, dashed curves). This clearly indicated a defect in nuclear pri-mir-26a2 processing induced by *DDX5* and *DDX17* knockdown.

A DDX5/DDX17-regulated intronic region influences both pri-mir-26a2 processing and splicing of the miRNA host intron {#SEC3-2}
--------------------------------------------------------------------------------------------------------------------

Both miR-26a2 and miR-26a1 stem-loops are genomically located within an intron of their respective paralogous genes *CTDSP2* and *CTDSPL* (Figure [2A](#F2){ref-type="fig"}). As described in the Introduction, a complex interplay exists between the *CTDSP* host genes and their products (miRNAs and proteins) during neurogenesis ([@B21]). Interestingly, we have previously shown that DDX5 and DDX17 regulate the splicing of *CTDSP2* transcripts ([@B26]). As shown in Figure [2B](#F2){ref-type="fig"}, the exon upstream of the mir-26a2-containing intron (exon 6) is skipped in absence of both RNA helicases (Figure [2B](#F2){ref-type="fig"}). In contrast, the inclusion of the corresponding exon in the *CTDSPL* gene (exon 8) was not affected by si*DDX5/DDX17* (Figure [2B](#F2){ref-type="fig"}). Since DDX5 and DDX17 also control the nuclear maturation of pri-mir-26a2 in differentiating cells (Figure [1](#F1){ref-type="fig"}), we explored in more details the mechanism that links the processing of the pri-mir-26a2 precursor to the splicing of its host *CTDSP2* intron 6.

![DDX5 and DDX17 ensure the correct processing of *CTDSP2*/miR-26a2 transcripts. (**A**) Genomic organization of *CTDSP2* and *CTDSPL* genes (NCBI Gene screenshots) showing the position of miR-26a2 and miR-26a1 within *CTDSP2* intron 6 and *CTDSPL* intron 8, respectively. Exon numbering is based on the FasterDB database ([@B78]), which reports exons (in brackets) not annotated by the NCBI. (**B**) RT-PCR analysis of *CTDSP2* and *CTDSPL* transcripts. The inclusion of the exon preceding the two miR-26a loci was monitored following treatment with control siRNA or si*DDX5/DDX17*. The size of the different PCR products (exon inclusion and exon skipping) is indicated. (**C**) RT-PCR analysis of *CTDSP2* exon 6 inclusion in stable MCF7 cell lines. Cells were treated with siRNA to silence endogenous *DDX5* and *DDX17* genes, and treated or not with doxycyclin to induce the expression of recombinant DDX17 (iDDX17) or DDX5 (iDDX5). (**D**) RT-qPCR analysis of pri-miR-26a2 in stable MCF7 cell lines. Experimental details are as in C. The ratio of pri-mir-26a2 precursor to total *CTDSP2* mRNA is represented as the mean value + S.E.M. of independent experiments (*n* = 3), normalized to the control condition (siCtrl without Doxycyclin). \**P*-value \< 0.05; \*\**P*-value \< 0.01 (Student\'s *t*-test). (**E**) Predicted folding of the RNA region encompassing *CTDSP2* exon 6 and pri-mir-26a2. The framed inset on top of the figure represents a linear view of the region. The black arrowhead indicates the site of the junction between the 2 sequence fragments used for the Mfold prediction (see Materials and Methods for details). Exon 6 (E6) and the pri-mir-26a2 hairpin are highlighted by thick blue lines. The thick black element indicates the 5′-located intronic sequence predicted to base-pair (double-headed arrow in the inset) with the lower stem of the pri-miRNA. The antisense competitor RNA (AON-26a2, in red) was designed to perfectly hybridize with the repressor element, in order to restore the correct folding of the pri-miRNA hairpin. (**F**) Competing with the intronic inhibitory structure rescues the pri-mir-26a2 processing defect in absence of DDX5/DDX17. The AON-26a2 (or a control AON) was transfected in cells along with control siRNA (siCtrl) or si*DDX5*/DDX17. The pri-mir-26a2 precursor and the *CTDSP2* mRNA were quantified by RT-qPCR. Data are represented as the mean values + S.E.M. of independent experiments (*n* = 4), normalized to the control condition (siCtrl + Ctrl AON), which was set to 1. \**P*-value \< 0.05; \*\**P*-value \< 0.01 (Student\'s *t*-test). (**G**) Competing with the intronic inhibitory structure rescues the inclusion defect of *CTDSP2* exon 6 in absence of DDX5/DDX17. Experimental design is as in panel D. Inclusion of *CTDSP2* exon 6 was analysed as in panel B. The percentage of spliced-in sequence (PSI) is indicated. (**H**) Inhibition of pri-mir-26a2 processing upon silencing of Drosha (*RNASEN*). Details are as in panel D. ( **I**) Silencing of Drosha (*RNASEN*) does not induce the skipping of *CTDSP2* exon 6 (measured as in panel B), showing that splicing and pri-mir-26a2 processing are intrinsically uncoupled processes.](gky545fig2){#F2}

We first hypothesized that DDX5 and DDX17 may be required to ensure the correct folding of the miR-26a-encoding intronic region, to make it accessible to both the spliceosome and the Microprocessor complex. As a first step to test the activity of these RNA helicases on the processing of this region, we used previously described stable inducible MCF7 cell lines expressing DDX5 or DDX17 proteins ([@B26],[@B43]). These cells were transfected with siRNAs targeting the 5′ or 3′ UTR of endogenous *DDX5* and *DDX17* mRNAs, respectively (siDDX-UTR). As in SH-SY5Y cells, this treatment resulted in *CTDSP2* exon 6 skipping in both cell lines (Figure [2C](#F2){ref-type="fig"}) and in an increase of unprocessed pri-miR-26a2 (Figure [2D](#F2){ref-type="fig"}). Reexpression of DDX5 or DDX17 induced by doxycyclin rescued the *CTDSP2* splicing pattern to a level comparable to the control level (full exon 6 inclusion), and also efficiently reduced the amount of pri-miR-26a2 (Figure [2C](#F2){ref-type="fig"} and [D](#F2){ref-type="fig"}). This experiment supported a direct role of DDX17 and DDX5 in regulating the processing of *CTDSP2*/pri-miR-26a2 transcripts. Note that these results also underlined the functional redundancy between the two proteins, since the expression of either DDX5 or DDX17 could efficiently compensate the double *DDX5/DDX17* knockdown.

Next, we used the Mfold web server ([@B48]) to predict whether RNA secondary structures may hinder the access to the 5′ splice site region of *CTDSP2* exon 6 and/or to the region encompassing the pri-mir-26a2 stem-loop. Significantly, some of the most stable predicted structures involved an intronic sequence located shortly downstream of the 5′ splice site, and which was predicted to make stable base-pairing with nucleotides localized 1.6 kilobases further downstream, on either side of the basal part of the pri-mir-26a2 stem-loop precursor (Figure [2E](#F2){ref-type="fig"} and [Supplementary Figure S1A](#sup1){ref-type="supplementary-material"}). By preventing the expected folding of the miRNA precursor, such structure could likely impair the binding and/or activity of the Drosha/DGCR8 complex ([@B51],[@B52]), and it may also be close enough to the exon 6 to sterically disturb the splicing process.

If RNA helicases are required to resolve this potential inhibitory structure, and thus to promote both exon 6 inclusion and pri-mir-26a2 cleavage, we reasoned that competing with the formation of the structure should contribute to restore normal splicing and pri-mir-26a2 processing when they are impaired upon knockdown of *DDX5* and *DDX17*. To this aim, we designed an antisense 2′-*O*-methylated RNA oligonucleotide (AON-26a2) that is perfectly complementary to the region predicted to disrupt the lower stem of pri-mir-26a2, (Figure [2E](#F2){ref-type="fig"} and [Supplementary Figure S1A](#sup1){ref-type="supplementary-material"}, highlighted in red). We transfected SH-SY5Y cells with AON-26a2 or with a non-specific AON, with or without si*DDX5/DDX17*. As expected, depletion of DDX5/DDX17 resulted in a strong increase of pri-mir-26a2 (Figure [2F](#F2){ref-type="fig"}). The AON-26a2 did not have any effect in presence of DDX5/DDX17 (Figure [2F](#F2){ref-type="fig"}, grey bars), but it significantly reduced the pri-mir-26a2 maturation defect induced by *DDX5* and *DDX17* knockdown (Figure [2F](#F2){ref-type="fig"}, blue bars). In a remarkable manner, the AON-26a2 also partially restored the inclusion of *CTDSP2* exon 6 in DDX5/DDX17-depleted cells (Figure [2G](#F2){ref-type="fig"}). This suggested that the same sequence can affect both miRNA biogenesis and splicing regulation. Importantly, the effect of AON-26a2 was specific of the *CTDSP2* gene. Indeed, even though *DDX5/DDX17* knockdown slightly increased the amount of unprocessed pri-mir-26a1, this defect was not restored by AON-26a2, and *CTDSPL* splicing remained unaffected in all conditions ([Supplementary Figure S1B](#sup1){ref-type="supplementary-material"}).

The restored inclusion of *CTDSP2* exon 6 by AON-26a2 could indirectly result from the more efficient pri-mir-26a2 processing, as both splicing and maturation of intronic miRNAs are thought to be coupled ([@B53]). To test this hypothesis, we impaired pri-mir-26a2 processing using siRNAs against Drosha (RNASEN), the enzyme that cleaves the primary miRNA precursor (si*RNASEN*, [Supplementary Figure S1C](#sup1){ref-type="supplementary-material"}). As shown in Figure [2H](#F2){ref-type="fig"}, Drosha knockdown strongly impaired pri-mir-26a2 processing, but it had no effect on exon 6 splicing (Figure [2I](#F2){ref-type="fig"}). These results indicate that both exon 6 splicing and pri-mir-26a2 processing are mechanistically uncoupled, but they probably rely on the capacity of DDX5 and DDX17 helicases to resolve antagonistic secondary structures within *CTDSP2* intron 6.

The expression of DDX17 and DDX5 is decreased during neuronal differentiation and *DDX17* is a direct target of miR-26a/b {#SEC3-3}
-------------------------------------------------------------------------------------------------------------------------

In the course of our work, we observed that the expression of both DDX17 and DDX5 was gradually repressed during ATRA-induced differentiation of two different neuroblastoma cell lines, as was REST expression that we used as a control ([@B16]) (Figure [3A](#F3){ref-type="fig"} and [Supplementary Figure S2A](#sup1){ref-type="supplementary-material"} and S2B). Investigating possible mechanisms that could explain this decrease, we found that potential sites for several neuron-enriched miRNAs are predicted within the 3′ untranslated regions (UTR) of both genes. Of particular interest, miR-26a/b and miR-9 were both predicted to target the *DDX17* 3′ UTR (Figure [3B](#F3){ref-type="fig"}). Overexpression of any of these 3 miRNAs in SH-SY5Y cells reproducibly decreased the endogenous DDX17 protein level compared to a control miRNA (Figure [3C](#F3){ref-type="fig"}). As positive controls, we confirmed that miR-26a (and also miR-26b) represses the expression of its host gene *CTDSP2* ([Supplementary Figure S2C](#sup1){ref-type="supplementary-material"}), and that the expression of REST was efficiently repressed by miR-9 ([Supplementary Figure S2D](#sup1){ref-type="supplementary-material"}) ([@B15],[@B16],[@B21]). Interestingly, the 3′ UTR of *REST* also contains predicted miR-26a/b binding sites, and we observed that miR-26b significantly reduced endogenous REST protein level ([Supplementary Figure S2D](#sup1){ref-type="supplementary-material"}). A similar trend was observed with miR-26a, although it did not reach statistical significance. In contrast, neither miR-9, nor miR-26a/b had a significant effect on endogenous CoREST ([Supplementary Figure S2D](#sup1){ref-type="supplementary-material"}).

![Downregulation of DDX17 and DDX5 during neuronal differentiation. (**A**) Western-blot analysis showing the decreased expression of DDX17 and DDX5 during differentiation of SH-SY5Y cells. The pro-proliferative MYCN protein, the neural cell adhesion molecule (NCAM1) and the neuronal gene repressors REST and CoREST were used as controls of differentiation. A larger REST immunoblot is shown in [Supplementary Figure S5](#sup1){ref-type="supplementary-material"}. (**B**) Prediction of neuronal miRNA binding sites in the 3′ UTR of *DDX17* transcripts (TargetScanHuman v6.2). The nucleotides deleted in the mutant DDX17-UTR construct are in bold. (**C**) Effect of overexpressed miR-26a/b and miR-9 on the expression of endogenous DDX17 in SH-SY5Y cells. The quantification of the experiment is shown at the bottom. The amount of DDX17 is represented as the mean intensity of the signal normalized to GAPDH level ± S.E.M. (*n* = 4 independent experiments) \**P*-value \< 0.05; \*\**P*-value \< 0.01 (Student\'s *t* test). The DDX17 signal corresponds to addition of both p72 and p82 bands. (**D**) Luciferase assays showing the effect of miR-26a and miR-26b on the expression of wild-type and mutant *DDX17* 3′ UTR reporters. Relative luciferase units data are represented as the mean values ± S.E.M. of four independent experiments, normalized to the control sample set to 1. \**P*-value \< 0.05 (Student\'s *t* test).](gky545fig3){#F3}

We then carried out luciferase assays using reporters fused to the 3′ UTR of *DDX17* to directly address the relationship between miR-26a/b and their potential target site in this transcript. Luciferase activity from the *DDX17* reporter was significantly reduced upon expression of miR-26a or miR-26b, and fully restored when the predicted miR-26 binding site was mutated, demonstrating that DDX17 is a direct target for these two miRNAs (Figure [3D](#F3){ref-type="fig"}). We also carried out similar experiments using a reporter that contained a 1 kb-fragment of the *REST* 3′ UTR, but this gave more contrasted results. Both miR-26a and miR-26b reduced luciferase activity from the *REST* reporter to a similar extent (although statistical significance was reached only with miR-26b) ([Supplementary Figure S2E](#sup1){ref-type="supplementary-material"}). However, luciferase activity was not restored when we used a reporter carrying a mutation within the most conserved miR-26 binding site (data not shown), suggesting that the *REST* 3′UTR contains several miR-26 binding sites.

Beside their effect on *DDX17* and *REST* transcripts, a large number of miR-26a/b direct targets correspond to genes involved in neurogenesis ([@B54]), so the overexpression of these miRNAs may stimulate some aspects of neuronal differentiation, as shown for other miRNAs ([@B55]). Supporting this hypothesis, overexpression of miR-26a/b tended to increase the expression of neuronal proteins NCAM1 and Synapsin-1, as did miR-9 ([Supplementary Figure S2F](#sup1){ref-type="supplementary-material"}), although more experiments would be necessary to confirm this point. Note that we tried to block the action of miR-26a/b by transfecting SH-SY5Y cells with specific antisense oligonucleotides, but this had no visible effect on DDX17 expression after 5 days of differentiation (data not shown).

As for DDX17, the expression of DDX5 was also markedly inhibited during neuronal differentiation (Figure [3A](#F3){ref-type="fig"}). Several neuron-enriched miRNAs (miR-124, the miR-181 family, miR-125a/b or miR-132/212) are predicted to target the *DDX5* 3′ UTR, and we have previously shown that miR-181b directly targets *DDX5* 3′ UTR in HMEC cells ([@B26]). However, none of those miRNAs had a significant effect on endogenous DDX5 expression when overexpressed in SH-SY5Y cells (data not shown), and we do not know presently the mechanism that causes DDX5 downregulation during differentiation. Altogether, results of Figures [1](#F1){ref-type="fig"} to [3](#F3){ref-type="fig"} indicate that during the early stages of neuronal diferentiation, DDX17 and DDX5 are required for the expression of several neuronal miRNAs, including miR-26a/b, and they suggest that these miRNAs may then contribute to the downregulation of DDX17.

DDX5, DDX17 and REST corepress the expression of neuronal genes {#SEC3-4}
---------------------------------------------------------------

We next sought to understand the impact of DDX17 and DDX5 downregulation on gene expression, and we analysed the transcriptome of si*DDX5/DDX17*-treated SH-SY5Y cells by RNA-seq. In parallel, we analysed the transcriptome of cells treated with siRNA against *REST*. Neither REST protein nor *REST* RNA level was significantly affected by DDX5/DDX17 depletion, and *REST* silencing did not modify DDX5 or DDX17 expression levels (Figure [4A](#F4){ref-type="fig"} and [Supplementary Figure S3A](#sup1){ref-type="supplementary-material"}). Similarly, the expression of the REST cofactor CoREST was not modified upon silencing of any of those factors (Figure [4A](#F4){ref-type="fig"}). The silencing of *REST* significantly changed the expression of 130 genes, in an equivalent proportion of upregulated and downregulated genes ([Supplementary Table S1](#sup1){ref-type="supplementary-material"}). This included a number of previously known REST target genes, such as *SCG2, SNAP25, SYP* or *VGF* for example ([Supplementary Table S1](#sup1){ref-type="supplementary-material"}) ([@B58]).

![Transcriptomic analysis of DDX5/DDX17 and REST-depleted cells. (**A**) Control western-blot for the knockdown of DDX5, DDX17 and REST upon treatment of SH-SY5Y cells with siRNA, as indicated. \* non-specific band. Larger REST immunoblots are shown in [Supplementary Figure S5](#sup1){ref-type="supplementary-material"}. (**B**) Scatter plot representation of gene expression in absence of DDX5/DDX17 and/or REST. The 2507 genes of which steady-state expression level is significantly altered only in the si*DDX5/DDX17*+si*REST* condition were ranked and plotted according to their expression level (blue dots). The Log2(FC) value for the same genes in condition of single depletion of DDX5/DDX17 (siDDX, orange dots) or REST (siREST, gray dots) was then plotted on the same graph, showing a positive correlation between the 3 conditions. The respective trend curves are shown (red and black lines). Functions significantly associated to genes upregulated or downregulated in double-knockdown cells (si*DDX5/DDX17*+si*REST*) indicate a link with neurogenesis and cell cycle, respectively (see also [Supplementary Tables S2 and S3](#sup1){ref-type="supplementary-material"}). (**C**) Gene expression analysis of selected genes in condition of knockdown of *REST* and/or *DDX5/DDX17*. RT-qPCR data are represented as the mean values ± S.E.M. of independent experiments (*n* = 4), normalized to the expression of the control sample (siGL2) set to 1. Statistical significance was assessed by a one-way ANOVA (Kruskal-Wallis test), of which *P*-value is indicated above each graph. The si*DDX5/DDX17*+si*REST* condition was also compared to the control and si*REST* conditions (\**P*-value \< 0.05; \*\**P*-value \< 0.01; \*\*\**P*-value \< 0.001, Dunn\'s test). (**D**) Gene expression analysis of the same genes in undifferentiated and differentiated neuroblastoma cells (upper panel: CLBMA2 cells; lower panel: SH-SY5Y cells). RT-qPCR data are represented as the mean values ± S.E.M. of independent experiments (*n* = 3), normalized to the expression of the control sample (undifferentiated cells) set to 1. \**P*-value \< 0.05; \*\**P*-value \< 0.01; \*\*\**P*-value \< 0.001 (Student\'s *t* test). The *LHX9* gene is not expressed in CLBMA2 cells.](gky545fig4){#F4}

To investigate a potential joint effect of REST and DDX5/DDX17 on gene expression, we analysed the expression of genes that were significantly regulated upon the combined silencing of both *REST* and *DDX5/DDX17* ([Supplementary Table S1](#sup1){ref-type="supplementary-material"}). We found a positive correlation between their expression in both single siRNA conditions (si*REST* or si*DDX5/DDX17*) and their expression in the double siRNA treatment (Figure [4B](#F4){ref-type="fig"}). Furthermore, this analysis highlighted the more pronounced effect of the double siRNA treatment (si*DDX5/DDX17*+si*REST*) on gene expression compared to the absence of REST or DDX5/DDX17, for both activated and repressed genes (Figure [4B](#F4){ref-type="fig"}). Notably, many of the genes that are upregulated in absence of REST and DDX5/DDX17 are functionally associated with neurogenesis, with an enrichment in cellular compartments such as synapses or cellular junctions (Figure [4B](#F4){ref-type="fig"} and [Supplementary Table S2](#sup1){ref-type="supplementary-material"}). In contrast, functions associated with the downregulated genes in the same condition point at a regulation of cell cycle and DNA replication (Figure [4B](#F4){ref-type="fig"} and [Supplementary Table S3](#sup1){ref-type="supplementary-material"}).

To further validate the cooperation between REST and DDX5/DDX17, we tested by RT-qPCR the expression of several genes, including known REST-targeted genes (*e.g. VGF, GRIA2, DNER, SYT4*) ([@B59]). We observed that all these genes were more derepressed upon the codepletion of the 3 factors than upon the silencing of only *REST* or *DDX5/DDX17* (Figure [4C](#F4){ref-type="fig"}). Finally, most of these genes are induced during neuronal differentiation of two different neuroblastoma cell lines (Figure [4D](#F4){ref-type="fig"}). These results strongly support the notion that a number of genes are derepressed during differentiation owing to the reduced expression of REST and DDX5/DDX17.

Interplay between DDX17 and REST recruitment at REST target promoters {#SEC3-5}
---------------------------------------------------------------------

Since regulation of a number of REST-targeted genes appears to require the coordinated action of REST and DDX17/DDX5, we sought to determine whether these RNA helicases could be considered as transcriptional coregulators of REST. We first investigated a possible interaction between REST and DDX17 and DDX5 in SH-SY5Y cells. Using proximity ligation assays (PLA), we showed that DDX17 is in close proximity of REST in multiple sites within the nuclei of undifferentiated SH-SY5Y cells (Figure [5A](#F5){ref-type="fig"} and [Supplementary Figure S4A](#sup1){ref-type="supplementary-material"}). After 6 days of differentiation, the number of interaction loci was strongly reduced (Figure [5A](#F5){ref-type="fig"} and [B](#F5){ref-type="fig"}), in line with the decreased expression of DDX17 and REST upon ATRA exposure (see Figure [3](#F3){ref-type="fig"}). Similar results were obtained when looking at proximity foci between DDX5 and REST ([Supplementary Figure S4B](#sup1){ref-type="supplementary-material"}). The interactions between endogenous REST and both DDX5 and DDX17 were confirmed by co-immunoprecipitation from SH-SY5Y cell extracts (Figure [5C](#F5){ref-type="fig"}), which further argued that at least a fraction of these factors are part of the same protein complex.

![DDX17 is a direct cofactor of REST. (**A**) Proximity-ligation assays (PLA) between REST and DDX17 proteins revealed numerous interaction sites, essentially restricted to DAPI-stained nuclei of undifferentiated SH-SY5Y cells (-ATRA, left). Upon 6 days of ATRA treatment, the signal was strongly diminished. Scale bar: 10 μm. (**B**) Quantification of PLA experiments. Statistical significance was calculated from a generalized linear model with Poisson regression. (**C**) Co-immunoprecipitation of endogenous REST with DDX17 and DDX5 in SH-SY5Y cells. Larger REST immunoblots are all shown in [Supplementary Figure S5](#sup1){ref-type="supplementary-material"}. (**D**) Enrichment of REST binding sites around genes that are upregulated in si*DDX5/DDX17*+si*REST*-treated cells (REST ChIP-seq datasets from ENCODE and CHEA, see also [Supplementary Table S2](#sup1){ref-type="supplementary-material"}). (**E**) Chromatin immunoprecipitation (ChIP)-qPCR experiments showing the binding of DDX17 and REST at the promoter of their target genes and at a control intergenic region (Neg.), in presence (black bars) or absence (red bars) of REST. Data are represented as the mean values of the percentage of input signal ± S.E.M. (*n* = 3 independent experiments). Control IgG for both conditions are represented by grey and white bars. (**F**) ChIP-qPCR experiments showing the enrichment of REST and EHMT2 at regulated promoters, in presence (black bars) or absence (blue bars) of DDX17/DDX5. Data are represented as the mean values ± S.E.M. (*n* = 3 independent experiments) of the fold increase in ChIP signal relative to the background signal (control IgG). (**G**) ChIP-qPCR experiments showing the DDX17/DDX5-independent binding of REST at the *LHFPL4* promoter that is regulated only by REST. Details as in E.](gky545fig5){#F5}

We next used public chromatin immunoprecipitation (ChIP)-seq datasets from ENCODE and ChIP enrichment analysis (ChEA) to look for enriched transcription factor binding sites at the promoter of genes that are specifically activated in the double *REST*+*DDX5/DDX17* knockdown condition. This revealed a strong enrichment of REST binding sites, as expected (Figure [5D](#F5){ref-type="fig"}, [Supplementary Table S2](#sup1){ref-type="supplementary-material"}). Accordingly, ChIP-qPCR experiments showed that REST bound to the REST/DDX17/DDX5-regulated promoters (Figure [5E](#F5){ref-type="fig"}, upper panel). DDX17 was also enriched at these promoters and its binding was inhibited by the silencing of *REST* (Figure [5E](#F5){ref-type="fig"}, lower panel). As a control, we detected some DDX17 binding on a non-regulated intergenic region that was not reduced upon *REST* silencing (Figure [5E](#F5){ref-type="fig"}, Neg.). Note that we could not determine whether DDX5 is also recruited to REST-targeted promoters as we did not succeed in performing ChIP with this factor in SH-SY5Y cells. Collectively, these observations suggest that DDX17 is recruited on REST-target promoters in a REST-dependent manner.

Interestingly, we observed that *DDX17/DDX5* silencing reduced REST binding to its target promoters (Figure [5F](#F5){ref-type="fig"}, left panel). Supporting the idea that DDX17/DDX5 are required for the assembly of a REST-dependent complex on repressed genes, the silencing of both RNA helicases also reduced the binding of EHMT2, a global REST corepressor (Figure [5F](#F5){ref-type="fig"}, right panel) ([@B9],[@B60]).

Finally, we also looked at REST and DDX17 binding to the promoter of the *LHFPL4* gene, which was regulated only by REST and not by DDX17/DDX5 ([Supplementary Figure S4C](#sup1){ref-type="supplementary-material"} and [Supplementary Table S1](#sup1){ref-type="supplementary-material"}). DDX17 bound weakly to this promoter, but in a REST-independent manner (Figure [5E](#F5){ref-type="fig"}, *LHFPL4* panel). In addition, REST interacted with the *LHFPL4* promoter in a DDX17/DDX5-independent manner (Figure [5G](#F5){ref-type="fig"}), in agreement with our previous observation that not all REST target genes are coregulated by DDX17/DDX5 ([Supplementary Table S1](#sup1){ref-type="supplementary-material"}).

Altogether, these experiments demonstrated that DDX17 (and possibly DDX5) is a *bona fide* transcriptional coregulator of REST and suggested that the combined loss of REST and DDX17 contributes to efficiently derepress a number or neuronal genes during neuronal differentiation.

DISCUSSION {#SEC4}
==========

In this study, we uncovered a novel major function of RNA helicases in the REST gene circuitry that regulates the early stages of neuronal differentiation (Figure [6](#F6){ref-type="fig"}). First, DDX17 and DDX5 co-repress a number of REST target genes, including genes that are induced during neuronal differentiation and that have neuron-associated functions (Figures [4](#F4){ref-type="fig"}--[5](#F5){ref-type="fig"}). Second, DDX5 and DDX17 control the processing of miR-26a2 precursor and are required for the biogenesis of other miRNAs during differentiation, which are known to target members of the REST complex, including REST itself and DDX17 (Figures [1](#F1){ref-type="fig"}--[3](#F3){ref-type="fig"} and [Supplementary Figure S2](#sup1){ref-type="supplementary-material"}). This likely contributes to the induction of REST-repressed neuronal genes.

![Model for the dual function of DDX17 in neural precursors. (**A**) Upon induction of differentiation, the *CTDSP2* gene produces primary transcripts that can be correctly processed only in presence of DDX17 and DDX5 RNA helicases. This allows the production of mature miR-26a that is a direct regulator of DDX17 expression. (**B**) DDX17 associates with REST to some of its target promoters, along with EHMT2 which is known to promote a repressive chromatin environment. Upon silencing of *DDX17/DDX5* genes, the binding of REST to promoters is weaker, and a subset of DDX17/DDX5- and REST-repressed neuronal genes are activated.](gky545fig6){#F6}

So far the activity of DDX5 and DDX17 in transcription regulation has been mostly studied in the context of the coactivation of various transcription factors ([@B29]). However, both proteins were shown to inhibit the transcription of a few transfected reporters by recruiting histone deacetylase 1 ([@B61]). To the best of our knowledge, this report is the first demonstration that DDX17 or DDX17 coregulates the activity of a major transcription repressor at a genome-wide scale. DDX17 binds in a REST-dependent manner to the promoter of their repressed genes (Figure [5](#F5){ref-type="fig"}), indicating that DDX17 is recruited on promoters by transcriptional repressors. Interestingly, we observed a reduced binding of REST and its cofactor EHMT2 in the absence of DDX5/DDX17 (Figure [5F](#F5){ref-type="fig"}), suggesting that these RNA helicases may stabilize the association of the whole REST complex to their target promoter. At this stage it remains to determine whether this is due to a cooperative binding of REST and DDX17 to DNA, or because the RNA helicase promotes a chromatin environment favourable for REST binding, or to another reason.

One hypothesis is that RNA helicases contribute, perhaps with long noncoding RNAs (lncRNA), to correctly position the transcription factor and its associated proteins at its target promoter, as scaffolding elements that would then allow the local modification of chromatin. Supporting this idea, the *Rmrp* lncRNA functionally mediates the interaction between DDX5 and RORγt ([@B30]), and another lncRNA, *MeXis*, was recently shown to control the binding of both DDX17 and liver X receptor to the promoter of their target gene, where it locally modified the chromatin architecture of this gene ([@B62]). As REST interacts with various lncRNAs that are thought to promote the assembly of chromatin modifying complexes to its target genes ([@B63],[@B64]), it will be important to determine whether the REST-associated function of DDX17 is linked to these (or other) lncRNAs, and whether this may participate to the establishment of repressive chromatin marks on their target promoters.

The processing of pri-miRNAs by the microprocessor relies on the precise positioning of Drosha and DGCR8 onto the precursor stem--loop, forming a complex of which stoichiometry and structure have been revealed recently ([@B52],[@B65]). Microprocessor assembly and pri-miRNA processing are regulated by many factors, which includes sequence elements ([@B66]), lncRNA ([@B69]), RNA binding proteins ([@B70]), as well as DDX5 and DDX17 RNA helicases ([@B32]). DDX17 has been shown to bind its target pri-miRNAs in a sequence-specific manner, either at the level of the stem-loop, or immediately downstream ([@B34],[@B71]). Yet, how RNA helicases precisely cooperate with the Microprocessor is unclear.

Our results on the regulation of pri-mir-26a2 processing help to clarify this relationship. We propose that an important function of DDX5 and DDX17 is to ensure the proper folding of the pri-miRNA stem-loop by destabilizing competing RNA structures that likely impair the assembly of Microprocessor. Interestingly, those RNA helicases regulate alternative splicing via a similar mechanism. DDX5 has been shown to destabilize inhibitory structures around the 5′ splice site of alternative exons in the *H-Ras* and *Tau* transcripts ([@B40],[@B41]), and our previous results indicated this could be a common feature of many DDX5/DDX17-regulated exons ([@B26]).

A majority of miRNAs is located within protein-coding or non-coding genes (reviewed in ([@B53])). Splicing and intronic pri-miRNA cleavage were initially described as two independent events that have little effect on each other ([@B72],[@B73]), at least for miRNAs that have a pure intronic localization (the situation is more complex for miRNAs overlapping splice sites and for mirtrons). This model was recently challenged as it was shown that the knockdown of splicing factors has a more specific and negative impact on the expression of intronic miRNAs compared to intergenic miRNAs ([@B74]). The results presented here may help to resolve this controversy. Our work suggests that intronic regulatory sequences can simultaneously affect the processing of an intronic miRNA precursor and the splicing of its host intron, but that both processes are mechanistically uncoupled. Indeed, the silencing of *RNASEN* (Drosha) altered pri-mir-26a2 maturation without affecting intron 6 splicing (Figure [2H](#F2){ref-type="fig"} and [I](#F2){ref-type="fig"}). An interesting hypothesis is that the processing of some pri-miRNAs is connected to the splicing of their host intron when their shared intronic environment is unfavorably structured, requiring the presence of helicases such as DDX5 or DDX17. Note that we cannot rule out that splicing of the host intron is a first step to allow pri-miR-26a2 processing, but, we could not test this possibility as we failed to force *CTDSP2* exon 6 skipping using specific antisense RNA or by knocking down the 70K subunit of U1 snRNP.

In addition to control miR-26a expression, DDX5 and DDX17 appear to be required for the biogenesis of other retinoic acid-induced miRNAs (Figure [1C](#F1){ref-type="fig"}), including miR-9 and miR-124, two major regulators of brain development ([@B13],[@B75]). Apart from miR-26a, our data do not allow at this stage to know whether all altered miRNAs are direct targets of DDX5 and/or DDX17, although evidence for direct regulation has been provided elsewhere, in different settings, for miR-132 and miR-181b ([@B26],[@B76]). It is interesting to underline that miR-9, miR-124 and miR-26a/b have a broad impact on the expression of several components of the REST complex. For example miR-9 reduces the expression of REST and DDX17 (Figure [3](#F3){ref-type="fig"} and [Supplementary Figure S2](#sup1){ref-type="supplementary-material"}) ([@B15]), while miR-124 targets CoREST ([@B18]). Moreover miR-26a targets its own *CTDSP2* transcript ([Supplementary Figure S2C](#sup1){ref-type="supplementary-material"} and ([@B21]), which codes for an RNA polymerase II CTD phosphatase that is a functional partner of REST in non-neuronal cells ([@B20]). We now show that miR-26a/b directly downregulate DDX17 and to a lesser extent REST (Figure [3](#F3){ref-type="fig"} and [Supplementary Figure S2](#sup1){ref-type="supplementary-material"}). Our data suggest that like in zebrafish ([@B21]), miR-26a/b have a positive influence on human neuronal differentiation ([Supplementary Figure S2F](#sup1){ref-type="supplementary-material"}), even if further experiments will be required to fully address this point.

This cocktail of miRNAs is essential for neurogenesis, as evidenced by their numerous mRNA targets in the mouse brain ([@B54]) and by their effect on the conversion of non-neuronal cells to neurons ([@B55]). Their coordinated targeting of the REST complex contributes to the inactivation of this complex. Taken individually, each of those miRNAs does not necessarily have a very strong effect on their target. However, as each miRNA targets several components of the REST complex, and REST complex components are often targeted by at least two different miRNAs, this supports a model in which different miRNA-related pathways efficiently converge toward the downregulation of the REST complex. Targeting multiple components from the same complex may be necessary to reach a threshold level of activity under which the expression of the targeted genes will be significantly affected. This may be crucial during neuronal differentiation, since the timing of gene expression must be precisely controlled from cell cycle exit to final neuronal maturation ([@B19]). In agreement with this hypothesis, we showed that *REST* silencing on its own has little effect on gene expression compared to the silencing of both *REST* and *DDX7/DDX5* (Figure [4](#F4){ref-type="fig"}). The coordinated targeting of several REST complex members may thus be necessary to promote the timely expression of neuronal genes.

Collectively, the complex interplay between RNA helicases, miRNAs and the REST complex is likely important to guarantee the robustness of this genetic circuit and the orchestration of the highly organized succession of events that shape the transcriptome of differentiating neuronal cells. DDX17, which is required both for the activity of REST and for the expression of miRNAs that downregulate REST complex components, is at the heart of mechanisms that control cell fate decisions.
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